Semaglutide shields human forebrain organoids from cholesterol-induced injury
Researchers report GLP-1 receptor activation engaged cAMP-PKA and PI3K-Akt-mTOR signaling, cutting lipid droplet buildup and stabilizing calcium activity under lipid stress.
PR
By Priya Raman · Science Reporter
Sep 29 13:33 ETSource: Alzheimer's & dementia : the journal of the Alzheimer's Association
The wire
- 01In Alzheimer's & Dementia, investigators exposed induced pluripotent stem cell-derived human forebrain organoids to cholesterol overload and found semaglutide reduced lipotoxic injury, oxidative stress and lipid droplet accumulation.
- 02Single-cell analysis indicated partial preservation of disrupted cell-to-cell communication including midkine signaling, adding a mechanistic candidate for why GLP-1 receptor agonists are being studied in neurodegeneration.
- 03This is an organoid model with expression signatures mapped against post mortem brain datasets; it does not demonstrate clinical benefit in patients with Alzheimer's disease.
From the source
Read at pubmed.ncbi.nlm.nih.govGLP-1R agonist semaglutide protects human forebrain organoids from cholesterol-induced neurotoxicity
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 Oct · Yu F, Xu J, Hou Y et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42805933/
